MiR-501-5p alleviates cardiac dysfunction in septic patients through targeting NR4A3 to prevent its binding with Bcl-2.

MLA

Gao, Lan, et al. “MiR-501-5p Alleviates Cardiac Dysfunction in Septic Patients through Targeting NR4A3 to Prevent Its Binding with Bcl-2.” Cell Cycle, vol. 21, no. 9, May 2022, pp. 961–71. EBSCOhost, https://doi.org/10.1080/15384101.2022.2035618.

APA

Gao, L., Zhai, Z., Shi, Q., Yan, J., Zhou, L., Wu, Y., Zeng, Q., Tian, G., & Li, H. (2022). MiR-501-5p alleviates cardiac dysfunction in septic patients through targeting NR4A3 to prevent its binding with Bcl-2. Cell Cycle, 21(9), 961–971. https://doi.org/10.1080/15384101.2022.2035618

Chicago

Gao, Lan, Zhongjie Zhai, Qindong Shi, Jinqi Yan, Linjing Zhou, Yongxin Wu, Qinjing Zeng, Gang Tian, and Hao Li. 2022. “MiR-501-5p Alleviates Cardiac Dysfunction in Septic Patients through Targeting NR4A3 to Prevent Its Binding with Bcl-2.” Cell Cycle 21 (9): 961–71. doi:10.1080/15384101.2022.2035618.